Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-13

FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Encube Ethicals, Inc.)

View source ↗

Summary

FDA approved Betamethasone Dipropionate as an original application from Encube Ethicals, Inc. (ANDA206389) for topical use in inflammatory dermatoses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BETAMETHASONE DIPROPIONATE (Betamethasone dipropionate)

Snippet

ORIG AP for BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE)